Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 95Breast Neoplasms 12Neoplasms 7Leiomyoma 4Rare Diseases 2Polycystic Ovary Syndrome 2Neoplasm Metastasis 2Adenocarcinoma 2Uveal Melanoma 1Uterine Neoplasms 1Urogenital Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Skin Neoplasms 1Skin Diseases 1Sexual Dysfunction, Physiological 1Respiratory Tract Diseases 1Prostatic Diseases 1Primary Dysautonomias 1Premenopausal Breast Cancer 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Patient Compliance 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neoplasms, Glandular and Epithelial 1Myofibroma 1Myelodysplastic Syndromes 1Melanoma 1Lymphatic Metastasis 1Lower Urinary Tract Symptoms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1

Interventions

Gemcitabine 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3Ocoxin 2Metformin 2Clomiphene 2relacorilant 1pralsetinib 1pembrolizumab 1parathyroid hormone-related peptide (1-36) 1niraparib 1napabucasin 1Spironolactone 1Paclitaxel 1Octreotide 1Leuprolide 1Irinotecan 1Immune Checkpoint Inhibitors 1Filgrastim 1Eating 1Cisplatin 1Chorionic Gonadotropin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Endocrine System Diseases × Leuprolide × Clear all
NCT00004311 2005-06-24

Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome

Office of Rare Diseases (ORD)

Phase 2 Completed

Acanthosis Nigricans, Endocrine System Diseases, Polycystic Ovary Syndrome, Skin Diseases, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡